140 related articles for article (PubMed ID: 36916517)
1. Psychosocial impact of pyoderma gangrenosum: a patient perspective.
Crowder D; Herbert S; Haughton R
Br J Dermatol; 2023 Jul; 189(1):125-128. PubMed ID: 36916517
[No Abstract] [Full Text] [Related]
2. Pyoderma gangrenosum: from misdiagnosis to recognition, a personal perspective.
Hemp L; Hall S
J Wound Care; 2009 Dec; 18(12):521-6. PubMed ID: 20081578
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Münchausen syndrome with presentation simulating pyoderma gangrenosum.
Parent DJ; Krafft T; Noel JC; Askenasi R; Goldschmidt D; Heenen M; Linkowski P
J Am Acad Dermatol; 1994 Dec; 31(6):1072-4. PubMed ID: 7962767
[No Abstract] [Full Text] [Related]
4. Pyoderma gangrenosum and its impact on quality of life: a multicentre, prospective study.
Ighani A; Al-Mutairi D; Rahmani A; Weizman AV; Piguet V; Alavi A
Br J Dermatol; 2019 Mar; 180(3):672-673. PubMed ID: 30362501
[No Abstract] [Full Text] [Related]
5. Quality of Life of Patients With Pyoderma Gangrenosum and Hidradenitis Suppurativa.
Gerard AJ; Feldman SR; Strowd L
J Cutan Med Surg; 2015; 19(4):391-6. PubMed ID: 25775617
[TBL] [Abstract][Full Text] [Related]
6. Pyoderma gangrenosum in a patient with essential thrombocythemia.
King KW; Murray A
J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
[TBL] [Abstract][Full Text] [Related]
7. [Lung involvement in pyoderma gangrenosum: a case report and review of the literature].
Batalla A; Pérez-Pedrosa A; García-Doval I; González-Barcala FJ; Rosón E; de la Torre C
Actas Dermosifiliogr; 2011 Jun; 102(5):373-7. PubMed ID: 21397890
[TBL] [Abstract][Full Text] [Related]
8. Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.
Dasanu CA; Bockorny B; Alexandrescu DT
J Oncol Pharm Pract; 2015 Dec; 21(6):471-3. PubMed ID: 24986794
[TBL] [Abstract][Full Text] [Related]
9. Vegetative pyoderma gangrenosum.
Kim RH; Lewin J; Hale CS; Meehan SA; Stein J; Ramachandran S
Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526339
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of pyoderma gangrenosum: case report and review.
Alam M; Grossman ME; Schneiderman PI; Blume RS; Benvenisty AI
Dermatol Surg; 2000 Nov; 26(11):1063-6. PubMed ID: 11096397
[TBL] [Abstract][Full Text] [Related]
11. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
Shenefelt PD
Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
Krauze E; Brzezińska-Wcisło L; Kamińska-Winciorek G; Wygledowska-Kania M; Sygula E
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):589-92. PubMed ID: 16164714
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitors-associated pyoderma gangrenosum, a systematic review of published case reports.
Khoshnam-Rad N; Gheymati A; Jahangard-Rafsanjani Z
Anticancer Drugs; 2022 Jan; 33(1):e1-e8. PubMed ID: 34282745
[TBL] [Abstract][Full Text] [Related]
14. Pyoderma gangrenosum with pulmonary involvement?
Liu ZH; Lu XL; Fu MH; Zhang GY; Liu WD
Eur J Dermatol; 2008; 18(5):583-5. PubMed ID: 18693166
[TBL] [Abstract][Full Text] [Related]
15. Familial ulcerative pyoderma gangrenosum: a report of 2 kindred.
Alberts JH; Sams HH; Miller JL; King LE
Cutis; 2002 Jun; 69(6):427-30. PubMed ID: 12078842
[TBL] [Abstract][Full Text] [Related]
16. Pyoderma gangrenosum: a rare complication of reduction mammaplasty - a case report.
Široká M; Kiss K; Fibír A
Acta Chir Plast; 2021; 63(2):69-72. PubMed ID: 34404220
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma gangrenosum at multiple sites in a post-colostomy ulcerative colitis patient with chronic hepatitis B virus: A case report.
Wang B; Liu T; Liu F; He YL
Int Wound J; 2020 Feb; 17(1):187-190. PubMed ID: 31663272
[TBL] [Abstract][Full Text] [Related]
18. Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases.
Yamaguchi Y; Yanagi T; Sato K; Yoshimoto N; Hirata Y; Ujiie I; Nishimura M; Natsuga K; Shiiya C; Tsukinaga I; Shimizu H
J Dermatol; 2018 Apr; 45(4):483-486. PubMed ID: 29235669
[TBL] [Abstract][Full Text] [Related]
19. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine.
Futami H; Kodaira M; Furuta T; Hanai H; Kaneko E
J Gastroenterol; 1998 Jun; 33(3):408-11. PubMed ID: 9658322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
